205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
19.06%
Some net income increase while AVGO is negative at -9.78%. John Neff would see a short-term edge over the struggling competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
503.40%
Some yoy increase while AVGO is negative at -33.99%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
83.58%
Operating cash flow growth above 1.5x AVGO's 7.23%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-48.00%
Both yoy lines negative, with AVGO at -44.00%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
100.00%
Acquisition growth of 100.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-9.43%
Negative yoy purchasing while AVGO stands at 45.71%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
37.98%
Below 50% of AVGO's 333.33%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
No Data
No Data available this quarter, please select a different quarter.
2.45%
Lower net investing outflow yoy vs. AVGO's 23.56%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
933.33%
Issuance growth of 933.33% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
41.67%
We have some buyback growth while AVGO is negative at -107.07%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.